Replies to post #83633 on Biotech Values

[DewDiligence]

MNTA:

For example, the DRG for a patient with a pulmonary embolus would be fixed and within that reimbursement the hospital would pay for meds, e.g. Lovenox, room rate, nursing care, IV’s, etc.

Perhaps this is what zipjet meant to say when he was talking about a fixed payment per procedure (rather than per diagnosis).

In any case, to the extent that inpatient use of Lovenox is reimbursed in the above manner, the rationale for using the lower-priced generic is even more compelling than in the outpatient setting where the generic “merely” saves the user on the co-pay.